Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal, and societal aspects of this research. The first function is fulfilled by the peer-reviewed research section, the second by the expository efforts in the front of the journal. We provide researchers with news about business; we provide the business community with news about research developments.
The core areas in which we are actively seeking research papers include: molecular engineering of nucleic acids and proteins; molecular therapy (therapeutics genes, antisense, siRNAs, aptamers, DNAzymes, ribozymes, peptides, proteins); large-scale biology (genomics, functional genomics, proteomics, structural genomics, metabolomics, etc.); computational biology (algorithms and modeling), regenerative medicine (stem cells, tissue engineering, biomaterials); imaging technology; analytical biotechnology (sensors/detectors for analytes/macromolecules), applied immunology (antibody engineering, xenotransplantation, T-cell therapies); food and agricultural biotechnology; and environmental biotechnology. A comprehensive list of areas of interest is shown below.
Genetic engineering
Strategies for controlling gene expression
Strategies for manipulating gene structure
Strategies for gene containment
Large-scale approaches
Technologies for analyzing gene function (e.g., arrays, SAGE)
Technologies for analyzing gene structure/organization (e.g., molecular beacons)
Chemogenomics or chemical genetics
Pharmacogenomics/SNPs
Computational analysis
Proteomics
Technologies for analyzing/identifying protein structure/function (e.g., 2-D gels, mass spectrometry, yeast two-hybrid, SPR, NMR, arrays and chips)
Structural genomics
Computational analysis
Metabolomics
Technologies for analyzing/profiling metabolites (chromatography, mass spectrometry)
Computational analysis
Computational biology
Bioinformatics; algorithms; data deconvolution
Modeling and systems biology: kinetics-based models and constraints-based models
Molecular engineering
Rational approaches for proteins/antibodies/enzymes/drugs
Molecular evolution
Molecular breeding approaches
Metabolic engineering
Genetic manipulation of species of interest to modify or allow the production of a commercially or therapeutically relevant compound
Computational analysis
Novel expression systems
Mammalian cells
Insect cells
Bacteria
Fungi
Plant cells
Delivery of genes, drugs, or cells
Targeting strategies
Viral and nonviral vector strategies
Imaging
Reporter molecules
Imaging approaches/technologies for visualizing whole animals, cells, or single molecules
Computational analysis
Nucleic acid therapeutics
Gene therapy (targeting, expression, integration, immunogenicity)
Antisense
RNAi
DNAzymes and ribozymes
Other (e.g., chimeric oligonucleotides/triple helix)
Nanobiotechnology
Nanomaterials for use in drug delivery or as therapeutics
Nanomaterials for use in industrial biotechnology
Nanosensors
Nanosystems for imaging molecules and cells
Vaccines and applied immunology
Antibody engineering
T-cell therapies
Therapies exploiting innate immunity (e.g. complement)
Antigen delivery vectors and approaches
Nucleic acid vaccines
Computational analysis
Regenerative medicine
Stem cells
Tissue engineering
Therapeutic cloning (somatic cell nuclear transfer)
Xenotransplantation
Biomaterials
Biosensors
Approaches for detecting biological molecules
Use of biological systems in detecting analytes
Assay systems
Approaches for multiplexing and increasing throughput
Selection/screening strategies for gene/proteins/drugs
Microfluidics
Biomaterials
Engineering materials for biological application
Molecular imprinting
Biomimetics
Nanotechnology
Agbiotech and transgenic plants
Crop improvement (resistance to stress, disease, pests)
Nutraceuticals
Forest biotechnology
Plant vaccines
Plants as bioreactors
Gene-containment strategies
Pharming
Transgenic animals
Knockouts
Reproductive cloning
Biopharmaceutical and enzyme production
Transgene targeting and expression strategies
Environmental
Bioremediation
Biomining
Phytoremediation
Monitoring
The core areas in which we are actively seeking research papers include: molecular engineering of nucleic acids and proteins; molecular therapy (therapeutics genes, antisense, siRNAs, aptamers, DNAzymes, ribozymes, peptides, proteins); large-scale biology (genomics, functional genomics, proteomics, structural genomics, metabolomics, etc.); computational biology (algorithms and modeling), regenerative medicine (stem cells, tissue engineering, biomaterials); imaging technology; analytical biotechnology (sensors/detectors for analytes/macromolecules), applied immunology (antibody engineering, xenotransplantation, T-cell therapies); food and agricultural biotechnology; and environmental biotechnology. A comprehensive list of areas of interest is shown below.
Genetic engineering
Strategies for controlling gene expression
Strategies for manipulating gene structure
Strategies for gene containment
Large-scale approaches
Technologies for analyzing gene function (e.g., arrays, SAGE)
Technologies for analyzing gene structure/organization (e.g., molecular beacons)
Chemogenomics or chemical genetics
Pharmacogenomics/SNPs
Computational analysis
Proteomics
Technologies for analyzing/identifying protein structure/function (e.g., 2-D gels, mass spectrometry, yeast two-hybrid, SPR, NMR, arrays and chips)
Structural genomics
Computational analysis
Metabolomics
Technologies for analyzing/profiling metabolites (chromatography, mass spectrometry)
Computational analysis
Computational biology
Bioinformatics; algorithms; data deconvolution
Modeling and systems biology: kinetics-based models and constraints-based models
Molecular engineering
Rational approaches for proteins/antibodies/enzymes/drugs
Molecular evolution
Molecular breeding approaches
Metabolic engineering
Genetic manipulation of species of interest to modify or allow the production of a commercially or therapeutically relevant compound
Computational analysis
Novel expression systems
Mammalian cells
Insect cells
Bacteria
Fungi
Plant cells
Delivery of genes, drugs, or cells
Targeting strategies
Viral and nonviral vector strategies
Imaging
Reporter molecules
Imaging approaches/technologies for visualizing whole animals, cells, or single molecules
Computational analysis
Nucleic acid therapeutics
Gene therapy (targeting, expression, integration, immunogenicity)
Antisense
RNAi
DNAzymes and ribozymes
Other (e.g., chimeric oligonucleotides/triple helix)
Nanobiotechnology
Nanomaterials for use in drug delivery or as therapeutics
Nanomaterials for use in industrial biotechnology
Nanosensors
Nanosystems for imaging molecules and cells
Vaccines and applied immunology
Antibody engineering
T-cell therapies
Therapies exploiting innate immunity (e.g. complement)
Antigen delivery vectors and approaches
Nucleic acid vaccines
Computational analysis
Regenerative medicine
Stem cells
Tissue engineering
Therapeutic cloning (somatic cell nuclear transfer)
Xenotransplantation
Biomaterials
Biosensors
Approaches for detecting biological molecules
Use of biological systems in detecting analytes
Assay systems
Approaches for multiplexing and increasing throughput
Selection/screening strategies for gene/proteins/drugs
Microfluidics
Biomaterials
Engineering materials for biological application
Molecular imprinting
Biomimetics
Nanotechnology
Agbiotech and transgenic plants
Crop improvement (resistance to stress, disease, pests)
Nutraceuticals
Forest biotechnology
Plant vaccines
Plants as bioreactors
Gene-containment strategies
Pharming
Transgenic animals
Knockouts
Reproductive cloning
Biopharmaceutical and enzyme production
Transgene targeting and expression strategies
Environmental
Bioremediation
Biomining
Phytoremediation
Monitoring
All submissions to the journal must be submitted online at http://mts-nbt.nature.com/cgi-bin/main.plex.